Get the latest tech news
GLP-1s are breaking life insurance
Patients look healthy on paper. Two years later, they're high-risk again.
Typically, underwriters- suspiciously sounds like undertakers- rely on a handful of key health metrics like HbA1c, cholesterol, blood pressure, and BMI to calculate your risk of dying earlier than expected (and thus costing them money). These partnerships could easily become multimillion-dollar deals, once generics and new GLP-1 entrants push prices down, opening the door to serving hundreds of thousands of customers every month and making this a fantastic win-win-win situation for patients, insurers and private companies. But my issue is we tend to overcomplicate solutions because we're drawn to elaborate, multi-layered strategies (umm, look at how much the NHS spent on McKinsey) when simpler fixes have worked brilliantly in the past.
Or read this on Hacker News